1-3 of 3
Victor Levitsky
Close
Sort by
Journal Articles

Novel Tumor-Targeted, Engineered IL-2 Variant (IL2v)-Based Immunocytokines For Immunotherapy Of Cancer

Christian Klein, PhD, Inja Waldhauer, PhD, Valeria Nicolini, PhD, Claire Dunn, PhD, Anne Freimoser-Grundschober, PhD, Gerrits Danny, PhD, Otto Boerman, PhD, Tapan Nayak, PhD, Sylvia Herter, PhD, Erwin Van Puijenbroek, Oliver Ast, PhD, Thomas Hofer, PhD, Ralf Hosse, Sabine Lang, Sebastian Neumann, Hubert Kettenberger, Markus Neubauer, Ingo Gorr, Dietrich Tuerck, Stefan Evers, Christian Gerdes, Victor Levitsky, Marina Bacac, Ekkehard Moessner, Pablo Umana, PhD
Journal: Blood
Blood (2013) 122 (21): 2278.
https://doi.org/10.1182/blood.V122.21.2278.2278
Published: 2013
Journal Articles

Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage–colony-stimulating factor and interleukin-4

LiQi Li, Daorong Liu, Lindsey Hutt-Fletcher, Andrew Morgan, Maria G. Masucci, Victor Levitsky
Journal: Blood
Blood (2002) 99 (10): 3725–3734.
https://doi.org/10.1182/blood.V99.10.3725
Published: 2002
Journal Articles

Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells

Åsa Gustafsson, Victor Levitsky, Jie-Zhi Zou, Teresa Frisan, Tina Dalianis, Per Ljungman, Olle Ringden, Jacek Winiarski, Ingemar Ernberg, Maria G. Masucci
Journal: Blood
Blood (2000) 95 (3): 807–814.
https://doi.org/10.1182/blood.V95.3.807.003k24_807_814
Published: 2000